Legal & General Group Plc - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 61 filers reported holding LOGICBIO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$14,000
-12.5%
1,961
-4.6%
0.00%
Q4 2020$16,000
+14.3%
2,056
+36.4%
0.00%
Q3 2020$14,000
-22.2%
1,507
-29.2%
0.00%
Q2 2020$18,000
+125.0%
2,130
+30.6%
0.00%
Q1 2020$8,000
-33.3%
1,6310.0%0.00%
Q4 2019$12,000
-14.3%
1,631
+29.5%
0.00%
Q3 2019$14,000
-12.5%
1,2590.0%0.00%
Q2 2019$16,000
+33.3%
1,2590.0%0.00%
Q1 2019$12,000
-7.7%
1,2590.0%0.00%
Q4 2018$13,0001,2590.00%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Lion Point Capital, LP 500,000$2,290,0000.43%
Orbimed Advisors 8,466,783$38,778,0000.43%
Sio Capital Management, LLC 182,630$836,0000.27%
Eversept Partners, LP 349,919$1,602,6290.11%
SAMLYN CAPITAL, LLC 1,474,108$6,752,0000.09%
PLATINUM INVESTMENT MANAGEMENT LTD 320,273$1,467,0000.04%
PURA VIDA INVESTMENTS, LLC 245,492$1,124,0000.03%
SANDERS MORRIS HARRIS LLC 35,000$160,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 176,500$808,0000.02%
Ergoteles LLC 65,827$301,0000.01%
View complete list of LOGICBIO THERAPEUTICS INC shareholders